Jump Financial, LLC Taysha Gene Therapies, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.43 - $3.25 $77,348 - $175,792	54,090 New	54,090 $155,000
Q4 2022 Feb 13, 2023	BUY	$1.39 - $2.98 $23,514 - $50,412	16,917 New	16,917 $38,000
Q2 2022 Aug 09, 2022	SELL	$2.47 - $6.77 $33,839 - $92,749	-13,700 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$5.22 - $11.86 $36,540 - $83,020	-7,000 Reduced 33.82%	13,700 $89,000
Q4 2021 Feb 10, 2022	BUY	$11.43 - $19.2 $236,601 - $397,440	20,700 New	20,700 $241,000

130

151M

48K

7.8K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $77.9M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.